2,4-dihydroxy-3-[3-[(1s,5s,6r,7s,9r,10s)-12-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.17,10.01,6]tridec-2-en-5-yl]propanoylamino]benzoic acid (C24H27NO8)

Structural Information

Molecular Formula

SMILES

C[C@@]1([C@@H]2[C@@H]3C[C@@H]4C[C@@]2(C=CC1=O)C([C@@]4(O3)C)O)CCC(=O)NC5=C(C=CC(=C5O)C(=O)O)O

InChI

InChI=1S/C24H27NO8/c1-22(7-6-16(28)25-17-13(26)4-3-12(18(17)29)20(30)31)15(27)5-8-24-10-11-9-14(19(22)24)33-23(11,2)21(24)32/h3-5,8,11,14,19,21,26,29,32H,6-7,9-10H2,1-2H3,(H,25,28)(H,30,31)/t11-,14+,19+,21?,22-,23-,24-/m1/s1

InChIKey

PATOIDCKGDRHNH-UFXDRCLESA-N

Compound name

2,4-dihydroxy-3-[3-[(1S,5S,6R,7S,9R,10S)-12-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.17,10.01,6]tridec-2-en-5-yl]propanoylamino]benzoic acid

Related CIDs

2D Structure

Predicted Collision Cross Section

m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Å²) per adduct calculated using CCSbase.
Adduct	m/z	Predicted CCS (Å²)
[M+H]+	458.180956	198.5
[M+Na]+	480.162898	202.3
[M-H]-	456.166404	197.4
[M+NH4]+	475.207503	217.2
[M+K]+	496.136838	199.9
[M+H-H2O]+	440.170940	194.9
[M+HCOO]-	502.171881	200.4
[M+CH3COO]-	516.187531	204.5
[M+Na-2H]-	478.148346	202.4
[M]+	457.17313142	204.1
[M]-	457.17422858	204.1

Adduct

m/z

Predicted CCS (Å²)

[M+H]+

458.180956

198.5

[M+Na]+

480.162898

202.3

[M-H]-

456.166404

197.4

[M+NH4]+

475.207503

217.2

[M+K]+

496.136838

199.9

[M+H-H2O]+

440.170940

194.9

[M+HCOO]-

502.171881

200.4

[M+CH3COO]-

516.187531

204.5

[M+Na-2H]-

478.148346

202.4

[M]+

457.17313142

204.1

[M]-

457.17422858

204.1

m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Å²) per adduct calculated using CCSbase.

2,4-dihydroxy-3-[3-[(1s,5s,6r,7s,9r,10s)-12-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.17,10.01,6]tridec-2-en-5-yl]propanoylamino]benzoic acid

Structural Information

2D Structure

Profile

Predicted Collision Cross Section

Literature stripe

Patent stripe